在患有抗脂综合征的患者中,低核酸酶活性和中性粒细胞-血小板总量的增加
Somanathapura K NaveenKumar1, Ajay Tambralli1,2, Bruna Mazetto Fonseca1,3
1Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI.
Blood
|January 18, 2024
概括
患有抗脂综合征的患者表现出减少的ectonucleotidase活性,促进中性粒细胞-血小板聚合. 在健康个体中,使用患者抗体或酶抑制剂来模仿这种效应.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 生物化学 生物化学
背景情况:
- 抗脂综合征 (APS) 是一种与血栓形成相关的自身免疫性疾病.
- 中性粒细胞和血小板激活是APS病变发生的关键事件.
- 细胞外核酸可以调节免疫细胞的功能.
研究的目的:
- 调查ectonucleotidase活动在APS中的作用.
- 了解抗脂抗体诱导中性粒细胞-血小板聚合的机制.
主要方法:
- 从APS患者的中性粒细胞和血小板中评估了ectonucleotidase活性.
- 用患者衍生的抗脂抗体治疗健康的中性粒细胞和血小板.
- 利用ectonucleotidase抑制剂来复制观察到的表型.
主要成果:
- 患有APS的患者表现出减少了ectonucleotidase活性.
- 减少了ectonucleotidase活性导致了细胞外核酸介导的中性粒细胞-血小板聚合物形成的增加.
- 来自患者的抗脂抗体和核酸酶抑制剂在健康细胞中重现了这种聚合.
结论:
- 减少ectonucleotidase活性是APS的一个关键特征,有助于中性粒细胞-血小板聚合.
- 抗脂抗体可能会损害ectonucleotidase的功能,从而促进前血栓状况.
- 向ectonucleotidase活性可能是APS的治疗策略.
更多相关视频
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
701
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
701
Formation of the Platelet Plug
6.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.3K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
525
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
525


